{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:54:49Z","timestamp":1777582489620,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemosphere"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.chemosphere.2014.06.093","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T08:16:41Z","timestamp":1407313001000},"page":"225-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Complement activation is involved in the hepatic injury caused by high-dose exposure of mice to perfluorooctanoic acid"],"prefix":"10.1016","volume":"129","author":[{"given":"Salom\u00e9 Calado","family":"Botelho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Saghafian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Pavlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustapha","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W.","family":"DePierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1985-6357","authenticated-orcid":false,"given":"Manuchehr","family":"Abedi-Valugerdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chemosphere.2014.06.093_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfm270","article-title":"Perfluoroalkyl acids and related chemistries\u2013toxicokinetics and modes of action","volume":"102","author":"Andersen","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/toxsci\/60.1.44","article-title":"Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats","volume":"60","author":"Biegel","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ieam.258","article-title":"Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins","volume":"7","author":"Buck","year":"2011","journal-title":"Integr. Environ. Assess. Manag."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yrtph.2004.03.003","article-title":"Characterization of risk for general population exposure to perfluorooctanoate","volume":"39","author":"Butenhoff","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0025","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1016\/j.scitotenv.2010.03.015","article-title":"Levels and trends of poly- and perfluorinated compounds in the arctic environment","volume":"408","author":"Butt","year":"2010","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.reprotox.2011.07.002","article-title":"Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys","volume":"33","author":"Chang","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0035","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1002\/eji.200425045","article-title":"Complement activation by necrotic cells in normal plasma environment compares to that by late apoptotic cells and involves predominantly IgM","volume":"34","author":"Ciurana","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0040","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0192623311428473","article-title":"Immunotoxicity of perfluorinated compounds: recent developments","volume":"40","author":"Dewitt","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.envint.2011.08.001","article-title":"Health risks of dietary exposure to perfluorinated compounds","volume":"40","author":"Domingo","year":"2012","journal-title":"Environ. Int."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00204-009-0424-0","article-title":"Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL\/6 mice","volume":"83","author":"Dong","year":"2009","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0055","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1289\/ehp.1104436","article-title":"Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure","volume":"120","author":"Gallo","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0060","article-title":"Alternative pathway evaluation","author":"Giclas","year":"2001","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0065","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1021\/es001834k","article-title":"Global distribution of perfluorooctane sulfonate in wildlife","volume":"35","author":"Giesy","year":"2001","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0070","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1021\/es052580b","article-title":"Biological monitoring of polyfluoroalkyl substances: a review","volume":"40","author":"Houde","year":"2006","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0075","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1021\/es1043613","article-title":"Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999\u20132008","volume":"45","author":"Kato","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0080","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/10408440490464705","article-title":"The toxicology of perfluorooctanoate","volume":"34","author":"Kennedy","year":"2004","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0085","series-title":"Fluorinated Surfactants and Repellents","year":"2001"},{"key":"10.1016\/j.chemosphere.2014.06.093_b0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.taap.2003.11.031","article-title":"The developmental toxicity of perfluoroalkyl acids and their derivatives","volume":"198","author":"Lau","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0095","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/toxsci\/kfm128","article-title":"Perfluoroalkyl acids: a review of monitoring and toxicological findings","volume":"99","author":"Lau","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0100","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.chemosphere.2004.11.078","article-title":"Synthesis of environmentally relevant fluorinated surfactants\u2013a review","volume":"58","author":"Lehmler","year":"2005","journal-title":"Chemosphere"},{"key":"10.1016\/j.chemosphere.2014.06.093_b0105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-3083.1988.tb02331.x","article-title":"Regulation of complement","volume":"27","author":"Mollnes","year":"1988","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000013568","article-title":"Significance of glomerular deposition of C3c and C3d in IgA nephropathy","volume":"20","author":"Nakagawa","year":"2000","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0120","unstructured":"OECD, 2002. Hazard assessment of perfluorooctane sulfonate (PFOS) and its salts. Organisation for Economic Co-operation and Development, Paris, France."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0125","unstructured":"OECD, 2005. Results of survey on production and use of PFOS, PFAS and PFOA, related substances and products\/mixtures containing these substances. Paris, France."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00420-007-0213-0","article-title":"Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers","volume":"81","author":"Olsen","year":"2007","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.chemosphere.2014.06.093_b0135","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0140","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/toxsci\/kfn059","article-title":"Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate","volume":"104","author":"Peden-Adams","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0145","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1021\/tx200316x","article-title":"Why toxic equivalency factors are not suitable for perfluoroalkyl chemicals","volume":"24","author":"Peters","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tox.2009.06.010","volume":"262","author":"Qazi","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.chemosphere.2014.06.093_b0155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tox.2009.03.009","volume":"260","author":"Qazi","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.chemosphere.2014.06.093_b0160","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.intimp.2010.08.009","article-title":"Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice","volume":"10","author":"Qazi","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0165","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.fct.2012.06.023","article-title":"High-dose dietary exposure of mice to perfluorooctanoate or perfluorooctane sulfonate exerts toxic effects on myeloid and B-lymphoid cells in the bone marrow and these effects are partially dependent on reduced food consumption","volume":"50","author":"Qazi","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2013.02.017","article-title":"Sub-acute, moderate-dose, but not short-term, low-dose dietary pre-exposure of mice to perfluorooctanoate aggravates concanavalin A-induced hepatitis","volume":"219","author":"Qazi","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0175","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/612089","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"2010","author":"Rakhshandehroo","year":"2010","journal-title":"PPAR Res."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0180","doi-asserted-by":"crossref","first-page":"962927","DOI":"10.1155\/2012\/962927","article-title":"Role of complement in multiorgan failure","volume":"2012","author":"Rittirsch","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1124\/jpet.111.189837","article-title":"Complement activation in acetaminophen-induced liver injury in mice","volume":"341","author":"Singhal","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jbt.2570070403","article-title":"Perfluorooctanoic acid has persistent effects on peroxisome proliferation and related parameters in mouse liver","volume":"7","author":"Sohlenius","year":"1992","journal-title":"J. Biochem. Toxicol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0195","doi-asserted-by":"crossref","first-page":"e61409","DOI":"10.1371\/journal.pone.0061409","article-title":"High fat diet feeding exaggerates perfluorooctanoic acid-induced liver injury in mice via modulating multiple metabolic pathways","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.chemosphere.2014.06.093_b0200","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00024382-199412000-00010","article-title":"Complement activation by the hydroxyl radical during intestinal reperfusion","volume":"2","author":"Turnage","year":"1994","journal-title":"Shock"},{"key":"10.1016\/j.chemosphere.2014.06.093_b0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clim.2013.11.014","article-title":"Complement activation correlates with liver necrosis and fibrosis in chronic hepatitis C","volume":"150","author":"Vasel","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0210","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0006-2952(01)00752-3","article-title":"Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice","volume":"62","author":"Yang","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0215","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1567-5769(01)00164-3","article-title":"Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid","volume":"2","author":"Yang","year":"2002","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0220","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0006-2952(02)00923-1","article-title":"Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice","volume":"63","author":"Yang","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.chemosphere.2014.06.093_b0225","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00204-008-0361-3","article-title":"Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL\/6 mice","volume":"83","author":"Zheng","year":"2009","journal-title":"Arch. Toxicol."}],"container-title":["Chemosphere"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045653514008558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045653514008558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:20:29Z","timestamp":1538353229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045653514008558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":45,"alternative-id":["S0045653514008558"],"URL":"https:\/\/doi.org\/10.1016\/j.chemosphere.2014.06.093","relation":{},"ISSN":["0045-6535"],"issn-type":[{"value":"0045-6535","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement activation is involved in the hepatic injury caused by high-dose exposure of mice to perfluorooctanoic acid","name":"articletitle","label":"Article Title"},{"value":"Chemosphere","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chemosphere.2014.06.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}